newsfilter
← Latest News
GlobeNewswire·

Adaptive Biotechnologies to Report Third Quarter 2026 Financial Results on November 4, 2026

SEATTLE, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (NASDAQ:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical